Clinical and molecular features of patients with cholangiocarcinoma harboring FGFR genetic alterations.

被引：6
|
作者：
Boileve, Alice
Baiev, Islam
Dinicola, Caroline
Horick, Nora K.
Tazdait, Melodie
Zhu, Andrew X.
Hollebecque, Antoine
Goyal, Lipika
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Gustave Roussy, Med Imaging, Villejuif, France
[4] Massachusetts Gen Hosp, Ctr Canc, Harvard Med Ctr, Boston, MA USA
[5] Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4084
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gunagratinib, a highly selective irreversible FGFR inhibitor, in patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR pathway alterations: A phase IIa dose-expansion study.
    Guo, Ye
    Yuan, Chunwang
    Ding, Weimin
    Gao, Yi
    Zhu, Xu
    Ying, Jieer
    Sun, Meili
    Zhang, Jingdong
    Zhuang, Zhixiang
    Huang, Yangqing
    Deng, Lichun
    Chen, Ping
    Bai, Yuxian
    Niu, Zuoxing
    Li, Wei
    Yin, Xiaoyu
    Xu, Aibing
    Cheng, Yufeng
    Li, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 572 - 572
  • [22] Non-small cell lung cancer (NSCLC) patients harboring mutations in FGFR2 and FGFR3: clinical and genomic features
    Scheffler, M.
    Chanra, T.
    Kron, A.
    Koleczko, S.
    Abdulla, D. S. Y.
    Ihle, M. A.
    Riedel, R.
    Michels, S.
    Fischer, R.
    Merkelbach-Bruse, S.
    Buettner, R.
    Nogova, L.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 112 - 112
  • [23] The Histologic and Molecular Features of Pediatric and Adult Gliomas with Alterations in FGFR1 and FGFR3
    Bale, Tejus A.
    Alexandrescu, Sanda
    Manam, Monica
    Lindeman, Neal I.
    Dubuc, Adrian
    Ligon, Azra H.
    Ligon, Keith L.
    LABORATORY INVESTIGATION, 2017, 97 : 429A - 429A
  • [24] The Histologic and Molecular Features of Pediatric and Adult Gliomas with Alterations in FGFR1 and FGFR3
    Bale, Tejus A.
    Alexandrescu, Sanda
    Manam, Monica
    Lindeman, Neal I.
    Dubuc, Adrian
    Ligon, Azra H.
    Ligon, Keith L.
    MODERN PATHOLOGY, 2017, 30 : 429A - 429A
  • [25] FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice
    Angerilli, Valentina
    Fornaro, Lorenzo
    Pepe, Francesco
    Rossi, Silvia Maria
    Perrone, Giuseppe
    Malapelle, Umberto
    Fassan, Matteo
    PATHOLOGICA, 2023, 115 (02) : 71 - 82
  • [26] Mechanisms of resistance to FGFR inhibitors in urothelial cancer cell lines and patients harboring FGFR3 alterations and strategies to overcome it
    Ruiz-Llorente, Sergio
    Fernandez-Sevillano, Elena
    Navarro, Paloma
    Francisco Rodriguez-Moreno, Juan
    Barquin-Garcia, Arantzazu
    Amarilla-Quintana, Sandra
    Yague-Fernandez, Monica
    Maria Roldan-Romero, Juan
    Martin, Raquel
    Rodriguez-Antona, Cristina
    Garcia-Donas, Jesus
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population
    Trachu, N.
    Sirachainan, E.
    Larbcharoensub, N.
    Rattanadech, W.
    Detarkom, S.
    Monnamo, N.
    Kamprerasart, K.
    MunTham, D.
    Sukasem, C.
    Reungwetwattana, T.
    ONCOTARGETS AND THERAPY, 2017, 10 : 4955 - 4968
  • [28] Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study
    Wen-Ming Cong
    Anke Bakker
    Patricia A. Swalsky
    Siva Raja
    Jeff Woods
    Stephen Thomas
    Anthony J. Demetris
    Sydney D. Finkelstein
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 187 - 192
  • [29] Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study
    Cong, WM
    Bakker, A
    Swalsky, PA
    Raja, S
    Woods, J
    Thomas, S
    Demetris, AJ
    Finkelstein, SD
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (03) : 187 - 192
  • [30] Clinical and molecular genetic features of Korean patients with GNE mutations
    Park, Y. E.
    Kim, H. S.
    Choi, E. S.
    Kim, S. Y.
    Kim, D. S.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 679 - 679
12345